Today’s Stocks: Rogers Corporation (NYSE:ROG), Avanir Pharmaceuticals (NASDAQ:AVNR), AngloGold (NYSE:AU), ICICI Bank Ltd. (NYSE:IBN), Yelp, Inc. (NYSE:YELP)

One such stock that you may want to consider dropping is Rogers Corporation (NYSE:ROG) which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year. A Zacks Rank #5 (Strong Sell) further confirms weakness in ROG. Rogers Corporation (NYSE:ROG) belongs to Technology sector. Its net profit margin is … Continue reading Today’s Stocks: Rogers Corporation (NYSE:ROG), Avanir Pharmaceuticals (NASDAQ:AVNR), AngloGold (NYSE:AU), ICICI Bank Ltd. (NYSE:IBN), Yelp, Inc. (NYSE:YELP)

Jayne Crisman08/0408/04

Trending Stocks : AT&T (NYSE:T), Sprint Corporation (NYSE:S), Avanir Pharmaceuticals (NASDAQ:AVNR), Booz Allen Hamilton (NYSE:BAH), Syngenta (NYSE:SYT)

Zacks reissued their outperform rating on shares of AT&T (NYSE:T) in a research report released on Wednesday morning. Zacks currently has a $12.00 price objective on the stock. AT&T, Inc. (NYSE:T)’s stock on 31 July traded at beginning with a price of $36.05 and when day-trade ended the stock finally fell -2.12% to end at $35.59. AT&T, Inc. (NYSE:T)’s showed weekly performance of 0.25%. Sprint … Continue reading Trending Stocks : AT&T (NYSE:T), Sprint Corporation (NYSE:S), Avanir Pharmaceuticals (NASDAQ:AVNR), Booz Allen Hamilton (NYSE:BAH), Syngenta (NYSE:SYT)

Mark Doerr08/0108/01

FB Nasdaq FB Facebook

Healthcare Gainers: BioScrip Inc (NASDAQ:BIOS), NPS Pharmaceuticals (NASDAQ:NPSP), RadNet Inc. (NASDAQ:RDNT), Avanir Pharmaceuticals Inc (NASDAQ:AVNR)

BioScrip Inc (NASDAQ:BIOS), on May 8, 2014 announced 2014 first quarter financial results. First quarter revenue from continuing operations was $239.6 million and the net loss from continuing operations was $25.4 million, or $0.37 per basic and diluted share. Non-GAAP adjusted loss from continuing operations per basic and diluted share was $0.13.BioScrip Inc (NASDAQ:BIOS) stock performance was 17.08% in last session and finished the day … Continue reading Healthcare Gainers: BioScrip Inc (NASDAQ:BIOS), NPS Pharmaceuticals (NASDAQ:NPSP), RadNet Inc. (NASDAQ:RDNT), Avanir Pharmaceuticals Inc (NASDAQ:AVNR)

Richard Atkins05/1205/12

Healthcare bearish stocks: Intrexon Corp (NYSE:XON), Cynosure (NASDAQ:CYNO), Capital Senior Living Corporation (NYSE:CSU), Avanir Pharmaceuticals (NASDAQ:AVNR)

Intrexon Corp (NYSE:XON) recently appointed James S. Turley. Mr. Turley’s effective direction of a global organization during some challenging economic times instilled the trust and confidence of key stakeholders, and Intrexon believes that his appointment to the Board as an independent director is in keeping with the best practices of corporate governance and providing guidance to the Company’s team. Intrexon Corp (NYSE:XON) stock performance was … Continue reading Healthcare bearish stocks: Intrexon Corp (NYSE:XON), Cynosure (NASDAQ:CYNO), Capital Senior Living Corporation (NYSE:CSU), Avanir Pharmaceuticals (NASDAQ:AVNR)

Jason Knox05/0805/08

NASDAQ Volatile Stocks: Westport Innovations (NASDAQ:WPRT), Pharmacyclics (NASDAQ:PCYC), QLogic Corporation (NASDAQ:QLGC), Avanir Pharmaceuticals Inc (NASDAQ:AVNR)

In trading on Thursday, shares of Westport Innovations, Inc.entered into oversold territory, hitting an RSI reading of 28.9, after changing hands as low as $12.71 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 58.2. A bullish investor could look at WPRT’s 28.9 RSI reading today as a sign that the recent heavy selling is in the process of … Continue reading NASDAQ Volatile Stocks: Westport Innovations (NASDAQ:WPRT), Pharmacyclics (NASDAQ:PCYC), QLogic Corporation (NASDAQ:QLGC), Avanir Pharmaceuticals Inc (NASDAQ:AVNR)

Jayne Crisman05/0505/05

Healthcare Most Active Movers: Bristol-Myers Squibb (NYSE:BMY), Ariad Pharmaceuticals (NASDAQ:ARIA), Avanir Pharmaceuticals (NASDAQ:AVNR), Rexahn Pharmaceuticals (NYSEMKT:RNN)

Zacks restated their neutral rating on shares of Bristol-Myers Squibb Co (NYSE:BMY) in a research note issued to investors on Wednesday. The firm currently has a $52.00 price target on the stock. Bristol-Myers Squibb Co (NYSE:BMY) stock performance was -1.14% in last session and finished the day at $49.52. Traded volume was 8.89million shares in the last session and the average volume of the stock … Continue reading Healthcare Most Active Movers: Bristol-Myers Squibb (NYSE:BMY), Ariad Pharmaceuticals (NASDAQ:ARIA), Avanir Pharmaceuticals (NASDAQ:AVNR), Rexahn Pharmaceuticals (NYSEMKT:RNN)

Kevin Long05/0205/02